Domača stranTKPHF • OTCMKTS
add
Takeda
Prejšnji trg. dan.
26,17 $
Dnevni razpon
24,25 $ - 24,25 $
Letni razpon
23,80 $ - 30,90 $
Tržna kapitalizacija
41,75 mrd. USD
Povprečni obseg
8,45 tis.
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
TYO
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (JPY) | sep. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 1,18 bil. | 12,75 % |
Stroški poslovanja | 540,19 mrd. | −10,33 % |
Čisti dohodek | 92,05 mrd. | 291,64 % |
Čista dobičkovnost prihodkov | 7,83 | 270,22 % |
Earnings per share | — | — |
EBITDA | 433,99 mrd. | 55,12 % |
Efektivna davčna stopnja | 22,84 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (JPY) | sep. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 859,02 mrd. | 170,09 % |
Skupna sredstva | 14,57 bil. | −2,01 % |
Skupne obveznosti | 7,65 bil. | −1,92 % |
Celoten lastniški kapital | 6,92 bil. | — |
Shares outstanding | 1,59 mrd. | — |
Razmerje P/B | 0,01 | — |
Donosnost sredstev | 3,92 % | — |
Donosnost kapitala | 4,57 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (JPY) | sep. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 92,05 mrd. | 291,64 % |
Denar iz dejavnosti | 280,96 mrd. | 41,25 % |
Denar iz naložb | −75,13 mrd. | −24,02 % |
Denar iz financiranja | −110,04 mrd. | 21,76 % |
Neto sprememba denarnih sredstev | 54,00 mrd. | 3.129,84 % |
Prost denarni tok | 97,22 mrd. | −39,87 % |
Vizitka
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
Generalni direktor
Datum ustanovitve
12. jun. 1781
Spletno mesto
Zaposleni
49.281
